Form 4 for ORIC Oric Pharmaceuticals, Inc.
Accepted 2021-09-16 00:00:00 ET · period of report 2021-09-14 · accession 0001209191-21-056461 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2021-09-16 | 2021-09-14+ | ORIC | Heyman Richard A. | Dir | S - Sale | $25.04 | -1,388 | 217.0K | -0.6% | -$34.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-15 | S | D | 682 | $25.03 | 216,272 | I See footnote | — | — | (F4) Represents the weighted average share price of an aggregate total of 682 shares sold in the price range of $25.00 to $25.19 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. (F3) The shares are held of record by RAHD Capital, LLC, and the Reporting Person has voting and investment power with respect to such shares. |
| 2 | Common | Common Stock | 2021-09-14 | S | D | 706 | $25.05 | 216,954 | I See footnote | — | — | (F2) Represents the weighted average share price of an aggregate total of 706 shares sold in the price range of $25.00 to $25.28 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. (F3) The shares are held of record by RAHD Capital, LLC, and the Reporting Person has voting and investment power with respect to such shares. |